RecruitingNot ApplicableNCT06386497

Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease

Overnight Treatment of Parkinson's Disease Using Vestibular Stimulation From a Rocking Bed (Somnomat Casa) - A Feasibility Study


Sponsor

Insel Gruppe AG, University Hospital Bern

Enrollment

15 participants

Start Date

Jan 11, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This pilot study aims to evaluate the feasibility and acceptability of nocturnal translational vestibular stimulations (VS) applied by a rocking bed (Somnomat Casa) for two months in patients with Parkinson's Disease.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study tests a rocking bed device called the Somnomat Casa to help people with Parkinson's disease sleep better. The gentle rocking motion may improve sleep quality, which is a common problem for people with Parkinson's. **You may be eligible if...** - You have been diagnosed with Parkinson's disease - You have poor sleep quality (score above 5 on a standard sleep questionnaire) - Your Parkinson's and sleep medications have been stable for at least 6 weeks - You do not have deep brain stimulation on both sides - You speak German fluently **You may NOT be eligible if...** - You have another brain disease (like Alzheimer's, multiple sclerosis, or stroke) - You have significant memory or thinking problems (dementia) - You weigh more than 150 kg (about 330 lbs) - You have active suicidal thoughts or severe uncontrolled psychiatric illness - You have poorly controlled diabetes, high blood pressure, or active cancer - You are already in another interventional study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENocturnal translational vestibular stimulation

Nocturnal (overnight) translational vestibular stimulation applied by the rocking bed (Somnomat Casa) for two months in patients familiar home environment.


Locations(2)

Insel Gruppe AG, University Hospital Bern

Bern, Switzerland

ETH Zurich, Sensory-Motor Systems Lab, IRIS

Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06386497


Related Trials